No recent security news found for Aimhubio.
| CVE ID | Severity | Patch | EPSS | Date |
|---|---|---|---|---|
| CVE-2025-51464 | ? N/A | UNKNOWN / UNPATCHED | 0.60% | 2025-07-22 |
| CVE-2025-5321 | 5.3 MEDIUM | UNKNOWN / UNPATCHED | 0.59% | 2025-05-29 |
| CVE-2024-8101 PoC | 7.2 HIGH | PATCH UNDER REVIEW | 0.23% | 2025-03-20 |
| CVE-2024-8769 | 9.1 CRITICAL | PATCH UNDER REVIEW | 0.91% | 2025-03-20 |
| CVE-2024-12777 | 5.9 MEDIUM | PATCH UNDER REVIEW | 0.46% | 2025-03-20 |
| CVE-2024-8238 | 5.9 MEDIUM | PATCH UNDER REVIEW | 0.75% | 2025-03-20 |
| CVE-2025-0189 | 7.5 HIGH | PATCH UNDER REVIEW | 0.62% | 2025-03-20 |
| CVE-2024-6829 | 9.1 CRITICAL | PATCH UNDER REVIEW | 0.87% | 2025-03-20 |
| CVE-2024-12778 | 7.5 HIGH | PATCH UNDER REVIEW | 0.76% | 2025-03-20 |
| CVE-2024-8061 | 7.5 HIGH | PATCH UNDER REVIEW | 0.46% | 2025-03-20 |
| CVE-2024-6851 | 7.5 HIGH | PATCH UNDER REVIEW | 0.99% | 2025-03-20 |
| CVE-2024-6483 | 5.3 MEDIUM | PATCH UNDER REVIEW | 0.85% | 2025-03-20 |
| CVE-2024-10110 | 7.5 HIGH | PATCH UNDER REVIEW | 0.61% | 2025-03-20 |
| CVE-2024-7760 | 7.4 HIGH | PATCH UNDER REVIEW | 0.51% | 2025-03-20 |
| CVE-2025-0190 | 7.5 HIGH | PATCH UNDER REVIEW | 0.62% | 2025-03-20 |
| CVE-2024-8863 | 5.3 MEDIUM | UNKNOWN / UNPATCHED | 0.50% | 2024-09-14 |
| CVE-2024-6578 | 7.2 HIGH | PATCH UNDER REVIEW | 0.28% | 2024-07-29 |
| CVE-2024-6396 PoC | 9.8 CRITICAL | PATCH UNDER REVIEW | 53.11% | 2024-07-12 |
| CVE-2024-6227 | 7.5 HIGH | PATCH UNDER REVIEW | 0.57% | 2024-07-08 |
| CVE-2024-2195 | 9.8 CRITICAL | PATCH UNDER REVIEW | 1.81% | 2024-04-10 |
Aimhubio is a software vendor that provides an open-source experiment tracking and management platform for machine learning, known as Aim. The platform allows data scientists and ML engineers to log, visualize, and compare AI experiments, with a focus on scalability and performance. Its cybersecurity relevance stems from potential vulnerabilities in its web-based UI and API that could expose sensitive model data or enable remote code execution, as reflected in its tracked CVEs.
Based on 4 critical CVEs, 0 CISA KEV, 100% unpatched. Model: GDPR Art.83 · not legal advice.